{"id":"levothyroxin","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Tachycardia","drugRate":"","severity":"common","organSystem":""},{"effect":"Palpitations","drugRate":"","severity":"common","organSystem":""},{"effect":"Tremors","drugRate":"","severity":"common","organSystem":""},{"effect":"Anxiety","drugRate":"","severity":"common","organSystem":""},{"effect":"Nervousness","drugRate":"","severity":"common","organSystem":""},{"effect":"Insomnia","drugRate":"","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"","severity":"common","organSystem":""},{"effect":"Weight loss","drugRate":"","severity":"common","organSystem":""},{"effect":"Heat intolerance","drugRate":"","severity":"common","organSystem":""},{"effect":"Excessive sweating","drugRate":"","severity":"common","organSystem":""},{"effect":"Increased appetite","drugRate":"","severity":"common","organSystem":""},{"effect":"Fatigue","drugRate":"","severity":"common","organSystem":""},{"effect":"Irritability","drugRate":"","severity":"common","organSystem":""},{"effect":"Emotional lability","drugRate":"","severity":"common","organSystem":""},{"effect":"Hyperactivity","drugRate":"","severity":"common","organSystem":""},{"effect":"Muscle weakness","drugRate":"","severity":"common","organSystem":""},{"effect":"Hair loss","drugRate":"","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"","severity":"common","organSystem":""},{"effect":"Abdominal cramps","drugRate":"","severity":"common","organSystem":""}],"contraindications":["Angina pectoris","Conduction disorder of the heart","Diabetes mellitus","Disorder of cardiovascular system","Disorder of coronary artery","Hypertensive disorder","Hyperthyroidism","Hypopituitarism","Myocardial infarction","Osteopenia","Osteoporosis","Primary adrenocortical insufficiency","Thyrotoxic crisis"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Myocardial infarction","drugRate":"","severity":"serious"},{"effect":"Cardiac arrest","drugRate":"","severity":"serious"},{"effect":"Heart failure","drugRate":"","severity":"serious"},{"effect":"Angina","drugRate":"","severity":"serious"},{"effect":"Arrhythmias","drugRate":"","severity":"serious"},{"effect":"Seizures","drugRate":"","severity":"serious"},{"effect":"Pseudotumor cerebri","drugRate":"","severity":"serious"},{"effect":"Slipped capital femoral epiphysis","drugRate":"","severity":"serious"},{"effect":"Craniosynostosis","drugRate":"","severity":"serious"},{"effect":"Angioedema","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":null,"aliases":["L-T4","neonatal screening","Thyroxine","BC-T4CYS 150 µg tablet (Berlin-Chemie AG)","Letrox® 150 µg tablet (Berlin-Chemie AG),"],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=levothyroxin","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:23:50.634160+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:23:56.391381+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=levothyroxin","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:23:56.859792+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Thyroid hormone receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:23:58.093092+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103741/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:23:57.567124+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"008de8fd-150f-4022-8ccb-c8bfa94875c7","title":"LEVOTHYROXINE SODIUM TABLET [A-S MEDICATION SOLUTIONS]"},"ecosystem":[],"mechanism":{"target":"THAP domain-containing protein 1, Macrophage migration inhibitory factor, Malate dehydrogenase, mitochondrial"},"_scrapedAt":"2026-03-27T23:52:04.765Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:23:59.388800+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Congenital hypothyroidism","diseaseId":"congenital-hypothyroidism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Diagnostic Test for Thyroid Dysfunction","diseaseId":"diagnostic-test-for-thyroid-dysfunction","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Goiter","diseaseId":"goiter","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hashimoto thyroiditis","diseaseId":"hashimoto-thyroiditis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hyperlipidemia","diseaseId":"hyperlipidemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hypothyroidism","diseaseId":"hypothyroidism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Malignant tumor of thyroid gland","diseaseId":"malignant-tumor-of-thyroid-gland","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Myxedema","diseaseId":"myxedema","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06731764","phase":"PHASE2, PHASE3","title":"Novel Approaches to the Treatment of Hypothyroidism","status":"RECRUITING","sponsor":"UConn Health","startDate":"2024-12-10","conditions":"Hypothyroidism","enrollment":90},{"nctId":"NCT06724224","phase":"","title":"Comparison of Levothyroxine Formulations in the Treatment of Congenital Hypothyroidism","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2024-04-08","conditions":"Congenital Hypothyroidism","enrollment":120},{"nctId":"NCT07463222","phase":"","title":"Neuroendocrine Response in Pediatric Febrile Seizures","status":"NOT_YET_RECRUITING","sponsor":"Aydin Adnan Menderes University","startDate":"2026-03","conditions":"Febrile Convulsion, Neuroendocrine Stress Response, Fever","enrollment":120},{"nctId":"NCT07424183","phase":"PHASE2","title":"T4/T3 Therapy in Hypothyroidism","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-03","conditions":"Hypothyroidism Primary","enrollment":60},{"nctId":"NCT07421869","phase":"NA","title":"SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial","status":"RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2024-06-12","conditions":"Hypothyroidism","enrollment":107},{"nctId":"NCT05526144","phase":"PHASE2","title":"Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-04-01","conditions":"Nonalcoholic Steatohepatitis, Liver Fibrosis","enrollment":128},{"nctId":"NCT06073665","phase":"PHASE4","title":"Dosing of LT4 in Older Individuals","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-01-31","conditions":"Hypothyroidism","enrollment":228},{"nctId":"NCT05712421","phase":"PHASE2","title":"A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism","status":"COMPLETED","sponsor":"Neuvosyn Laboratories, LLC","startDate":"2023-02-28","conditions":"Hypothyroidism","enrollment":303},{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":"Mild Cognitive Impairment, Dementia, Mild","enrollment":73},{"nctId":"NCT06647602","phase":"","title":"Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy","status":"NOT_YET_RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2026-09-01","conditions":"Differentiated Thyroid Cancer, Thyroid Cancer, Levothyroxine","enrollment":40},{"nctId":"NCT07393165","phase":"NA","title":"Levothyroxine Treatment on Cardiac Function in Children With Subclinical Hypothyroidism","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-05-24","conditions":"Levothyroxine, Cardiac Function, Children","enrollment":40},{"nctId":"NCT06790589","phase":"PHASE2","title":"COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer","status":"NOT_YET_RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2026-12","conditions":"Advanced Differentiated Thyroid Gland Carcinoma","enrollment":70},{"nctId":"NCT04743661","phase":"PHASE2","title":"131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pediatric Brain Tumor Consortium","startDate":"2022-04-04","conditions":"Recurrent Medulloblastoma, Recurrent Ependymoma","enrollment":62},{"nctId":"NCT07380854","phase":"NA","title":"Thyroid Hormone Replacement After Coronary Artery Bypass Grafting for Patients With Subclinical Hypothyroidism","status":"RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2022-02-27","conditions":"Subclinical Hypothyroidism","enrollment":338},{"nctId":"NCT01391962","phase":"PHASE2","title":"Sunitinib or Cediranib for Alveolar Soft Part Sarcoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2011-07-18","conditions":"Sarcoma, Alveolar Soft Part","enrollment":34},{"nctId":"NCT07346157","phase":"PHASE1, PHASE2","title":"Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease","status":"NOT_YET_RECRUITING","sponsor":"Sabine Mueller, MD, PhD","startDate":"2026-03-01","conditions":"Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent","enrollment":69},{"nctId":"NCT07257250","phase":"","title":"Levothyroxine Treatment and IVF Outcomes in Women With Subclinical Hypothyroidism: A Target Trial Emulation","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2019-01-01","conditions":"Subclinical Hypothyroidism, Infertility, Assisted Reproductive Technology","enrollment":900},{"nctId":"NCT07332273","phase":"PHASE3","title":"Levothyroxine as Adjuvant to a Hypocaloric Diet for the Treatment of Obesity.","status":"RECRUITING","sponsor":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","startDate":"2025-11-05","conditions":"Obesity","enrollment":286},{"nctId":"NCT07323706","phase":"NA","title":"Ayurvedic Diet in Myxedema","status":"RECRUITING","sponsor":"University of Copenhagen","startDate":"2024-10-01","conditions":"Hypothyroidism Primary","enrollment":88},{"nctId":"NCT06345339","phase":"PHASE2, PHASE3","title":"A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-04-26","conditions":"Hypothyroidism","enrollment":2800},{"nctId":"NCT04746313","phase":"","title":"Prevalence of Hyperprolactinemia in Systemic Scleroderma","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2021-03-01","conditions":"Sclerosis, Systemic, Scleroderma, Hyperprolactinemia","enrollment":71},{"nctId":"NCT07239674","phase":"PHASE3","title":"Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2025-11-30","conditions":"Intermediate-to-High Risk Differentiated Thyroid Cancer","enrollment":646},{"nctId":"NCT05228184","phase":"PHASE4","title":"Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)","status":"TERMINATED","sponsor":"IBSA Institut Biochimique SA","startDate":"2022-01-21","conditions":"Congenital Hypothyroidism","enrollment":34},{"nctId":"NCT04115514","phase":"PHASE2","title":"Treatment of ARDS With Instilled T3","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2020-03-30","conditions":"ARDS, Human, Lung, Wet, Thyroid","enrollment":68},{"nctId":"NCT03617835","phase":"PHASE1","title":"A Study in Healthy People to Measure the Amount of BI 655130 in the Blood After Injecting Different Doses Into Different Parts of the Body","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2018-08-16","conditions":"Healthy","enrollment":48},{"nctId":"NCT04290663","phase":"PHASE3","title":"Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up","status":"RECRUITING","sponsor":"Centre Francois Baclesse","startDate":"2020-03-02","conditions":"Thyroid Cancer, Intermediate Risk","enrollment":476},{"nctId":"NCT07205042","phase":"NA","title":"Walking for Hypothyroidism Trial (WHT)","status":"NOT_YET_RECRUITING","sponsor":"University of Karachi","startDate":"2025-11-01","conditions":"Hypothyroidism","enrollment":120},{"nctId":"NCT06083636","phase":"","title":"Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2022-07-26","conditions":"Hypothyroidism","enrollment":500},{"nctId":"NCT06652113","phase":"NA","title":"Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-11-15","conditions":"Recurrent Pregnancy Loss, Euthyroid With Thyroid Antibodies","enrollment":796},{"nctId":"NCT06455371","phase":"NA","title":"Patient-centered Dosage of Levothyroxine","status":"RECRUITING","sponsor":"University Hospital of North Norway","startDate":"2024-12-20","conditions":"Hypothyroidism, Thyroid Cancer, Thyroid","enrollment":240},{"nctId":"NCT03667664","phase":"NA","title":"PREPA PREvention of Loss of Autonomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2018-07-10","conditions":"Mobility Limitation, Physical Activity","enrollment":530},{"nctId":"NCT03977207","phase":"NA","title":"A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2020-07-20","conditions":"Thyroid; Functional Disturbance, Hypothyroidism, Hemodialysis","enrollment":336},{"nctId":"NCT06864351","phase":"NA","title":"Prospective Evaluation of OptiThyDose","status":"RECRUITING","sponsor":"University Children's Hospital Basel","startDate":"2025-08-28","conditions":"Thyroid Diseases, Congenital Hypothyroidism, Graves Disease","enrollment":150},{"nctId":"NCT06041204","phase":"NA","title":"Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism","status":"RECRUITING","sponsor":"Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy","startDate":"2021-05-06","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Subclinical Hypothyroidism, Female Infertility","enrollment":200},{"nctId":"NCT07133295","phase":"","title":"Long-Term Efficacy and Safety of Once-Weekly Levothyroxine Regimen in Hypothyroid Patients","status":"COMPLETED","sponsor":"Sohag University","startDate":"2021-03-23","conditions":"Hypothyroidism","enrollment":160},{"nctId":"NCT06660823","phase":"PHASE3","title":"Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-11-30","conditions":"Cardiac Surgery Intensive Care Treatment, Delayed Recovery From Anaesthesia, Euthyroid Sick Syndrome","enrollment":70},{"nctId":"NCT05293366","phase":"","title":"LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":"Long Covid-19","enrollment":100},{"nctId":"NCT05823012","phase":"PHASE2","title":"Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism","status":"COMPLETED","sponsor":"Xeris Pharmaceuticals","startDate":"2023-05-15","conditions":"Hypothyroidism","enrollment":46},{"nctId":"NCT05384847","phase":"PHASE1, PHASE2","title":"Effects of Triiodothyronine (T3) in Ischemic Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2022-12-02","conditions":"Heart Failure","enrollment":20},{"nctId":"NCT07011953","phase":"EARLY_PHASE1","title":"A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia","status":"NOT_YET_RECRUITING","sponsor":"Peking University","startDate":"2025-07-01","conditions":"Schizophrenia, Avolition","enrollment":90},{"nctId":"NCT06999278","phase":"PHASE3","title":"LIGHT Trial: Levothyroxine for Gestational Hypothyroidism in Recurrent Pregnancy Loss","status":"NOT_YET_RECRUITING","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2025-06-01","conditions":"Abortion, Habitual","enrollment":200},{"nctId":"NCT06983418","phase":"","title":"Euthyroid Sick Syndrome in Obesity Hypoventilation Syndrome","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2021-09-01","conditions":"Euthyroid Sick Syndrome, Obesity Hypoventilation Syndrome (OHS)","enrollment":49},{"nctId":"NCT06205303","phase":"NA","title":"Interventional Study to Improve Medication Adherence Using Patient Decision Aid","status":"RECRUITING","sponsor":"SingHealth Polyclinics","startDate":"2024-03-15","conditions":"Hypothyroidism","enrollment":236},{"nctId":"NCT06971965","phase":"NA","title":"Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Center, Korea","startDate":"2025-06-02","conditions":"Thyroid Cancer, Papillary Thyroid Carcinoma","enrollment":578},{"nctId":"NCT06154382","phase":"","title":"Eltroxin Administration to Patients With Extremely Low T4 Values in the Intensive Care Unit","status":"RECRUITING","sponsor":"Meir Medical Center","startDate":"2024-06-01","conditions":"Thyroid; Functional Disturbance","enrollment":350},{"nctId":"NCT06428097","phase":"PHASE1","title":"Levothyroxine Supplementation for Heart Transplant Recipients","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-03-29","conditions":"Heart Transplant Failure, Heart Transplant Infection","enrollment":97},{"nctId":"NCT06867913","phase":"NA","title":"A Study of Selenomethionine and Myo-inositol(SOLOWAYS_TM) in Patients With Autoimmune Thyroiditis Carrying the DIO2 Thr92Ala Polymorphism","status":"COMPLETED","sponsor":"S.LAB (SOLOWAYS)","startDate":"2024-05-15","conditions":"Autoimmune Thyroiditis","enrollment":40},{"nctId":"NCT06924242","phase":"","title":"Thyroid Cancer in Surgical Treated Multinodular Goiter","status":"COMPLETED","sponsor":"University of Foggia","startDate":"2018-01-01","conditions":"Goiter, Nodular, Total Thyroidectomy, Thyroid Cancer","enrollment":223},{"nctId":"NCT04202094","phase":"NA","title":"Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems","status":"ENROLLING_BY_INVITATION","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2020-09-08","conditions":"Childhood Cancer, Hematological Disorders","enrollment":50},{"nctId":"NCT06649318","phase":"","title":"Effect of Brain GABA Metabolite Amount to Propofol Utilisation Under TIVA in Hypothyroid Patient","status":"COMPLETED","sponsor":"Duzce University","startDate":"2023-06-23","conditions":"Hypothyroidism, Anesthesia, General, Propofol Dosage","enrollment":80},{"nctId":"NCT06276205","phase":"PHASE3","title":"Vitamin D & Levothyroxine Combination Versus Levothyroxine on Lipid Profile in Hypothyroidism","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2024-03-01","conditions":"Hypothyroidism Primary, Lipid Disorder, Dyslipidemias","enrollment":62},{"nctId":"NCT05682482","phase":"PHASE3","title":"LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.","status":"RECRUITING","sponsor":"M. Medici","startDate":"2022-10-07","conditions":"Autoimmune Hypothyroidism","enrollment":600},{"nctId":"NCT04111536","phase":"PHASE1, PHASE2","title":"Developing Oral LT3 Therapy for Heart Failure - HFpEF","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-03-08","conditions":"Heart Failure With Preserved Ejection Fraction, Low Triiodothyronine Syndrome","enrollment":28},{"nctId":"NCT03289403","phase":"PHASE2","title":"The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis","status":"COMPLETED","sponsor":"Aljazeera Hospital","startDate":"2018-03-07","conditions":"Infertility, Autoimmune Thyroiditis","enrollment":194},{"nctId":"NCT04112316","phase":"PHASE1, PHASE2","title":"Developing Oral LT3 Therapy for Heart Failure - HFrEF","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-02-11","conditions":"Heart Failure With Reduced Ejection Fraction (HFrEF), Low T3 Syndrome","enrollment":28},{"nctId":"NCT06735040","phase":"NA","title":"Effect of Photobiomodulation Therapy in Patients With Hashimoto's Thyroiditis","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2021-01-28","conditions":"Hashimoto Thyroiditis, Thyroiditis","enrollment":60},{"nctId":"NCT04754607","phase":"NA","title":"Effects of Low-Level Laser Therapy on Oxidative Stress Levels","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2021-02-09","conditions":"Hashimoto Thyroiditis, Autoimmune Thyroiditis, Thyroiditis","enrollment":46},{"nctId":"NCT06726967","phase":"","title":"Vitamin D, Hashimato's Thyroiditis and Thyroid Functions","status":"COMPLETED","sponsor":"Ankara Yildirim Beyazıt University","startDate":"2019-02-01","conditions":"Vitamin D, Thyroid Autoimmune Disease","enrollment":81180},{"nctId":"NCT06715176","phase":"","title":"TREM-1 Pathway in Predicting Treatment Outcomes in Periodontitis","status":"COMPLETED","sponsor":"Aydin Adnan Menderes University","startDate":"2016-12-19","conditions":"Periodontal Diseases","enrollment":123},{"nctId":"NCT03173521","phase":"PHASE1, PHASE2","title":"Gene Therapy in Patients With Mucopolysaccharidosis Disease","status":"COMPLETED","sponsor":"Fondazione Telethon","startDate":"2017-07-17","conditions":"Mucopolysaccharidosis Type VI","enrollment":9},{"nctId":"NCT03880578","phase":"","title":"Quality of Life After Interventional Thyroid Treatment","status":"COMPLETED","sponsor":"Klinikum Lüdenscheid","startDate":"2019-04-01","conditions":"Thyroid; Deficiency, Quality of Life","enrollment":101},{"nctId":"NCT06659484","phase":"","title":"Health Data from Well on My Legs Program","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2016-09-20","conditions":"Sarcopenia, Frailty, Physical Inactivity","enrollment":1600},{"nctId":"NCT06653907","phase":"PHASE4","title":"Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody","status":"NOT_YET_RECRUITING","sponsor":"Yang ZHANG","startDate":"2024-10-25","conditions":"Thyroid Abnormalities, Pregnant Woman, Pregnancy Outcomes","enrollment":400},{"nctId":"NCT06641440","phase":"PHASE4","title":"Treatment With Prednisone of Women With RPL or RIF Positive to Antithyroid Antibodies and Embryotoxicity Test","status":"COMPLETED","sponsor":"Centre for Endocrinology and Reproductive Medicine, Italy","startDate":"2018-01-01","conditions":"Recurrent Pregnancy Loss, Not Pregnant, Recurrent Implantation Failure","enrollment":42},{"nctId":"NCT06625814","phase":"PHASE1","title":"A Study of Levothyroxine and Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-028)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-07-08","conditions":"Healthy","enrollment":28},{"nctId":"NCT05412979","phase":"PHASE2","title":"A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism","status":"COMPLETED","sponsor":"Sention Therapeutics, LLC","startDate":"2022-04-29","conditions":"Hypothyroidism","enrollment":490},{"nctId":"NCT05276856","phase":"","title":"Recovery Rate in Secondary Hypothyroidism","status":"RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2022-04-04","conditions":"Secondary Hypothyroidism","enrollment":90},{"nctId":"NCT05918497","phase":"","title":"Comparison Between Variable Time Regimen of Dosing L-Thyroxine for Treatment Hypothyroid Fasting Ramadan","status":"COMPLETED","sponsor":"Sohag University","startDate":"2023-04-25","conditions":"Different Regimens in Treatment of Hypothyroidism During Fasting in Ramadan","enrollment":89},{"nctId":"NCT06547242","phase":"PHASE1","title":"Levothyroxine-sodium Bioequivalence Trial With Oral Single Dose Administration","status":"COMPLETED","sponsor":"Berlin-Chemie AG Menarini Group","startDate":"2021-10-22","conditions":"Healthy","enrollment":132},{"nctId":"NCT06373523","phase":"EARLY_PHASE1","title":"MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin","status":"NOT_YET_RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2024-09-01","conditions":"Hepatic Steato-Fibrosis, Non-Alcoholic Fatty Liver Disease","enrollment":60},{"nctId":"NCT06527859","phase":"","title":"Correlation Between Levothyroxine and Blood Th17/Treg in Pregnant Women With Normal-high TSH and Positive TPOAb","status":"TERMINATED","sponsor":"Third Affiliated Hospital of Zhengzhou University","startDate":"2022-04-06","conditions":"Pregnancy Related, Thyroid Stimulating; Hormone, C","enrollment":64},{"nctId":"NCT06480682","phase":"","title":"Relative Energy Deficiency in Sport and Dance","status":"NOT_YET_RECRUITING","sponsor":"University of Wolverhampton","startDate":"2024-09-10","conditions":"Relative Energy Deficiency in Sport, Bone Stress Reaction","enrollment":200},{"nctId":"NCT04782856","phase":"PHASE2","title":"Energy Metabolism in Thyroidectomized Patients","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2020-10-28","conditions":"Thyroid Goiter, Hypothyroidism, Thyroid Cancer","enrollment":13},{"nctId":"NCT04124705","phase":"PHASE2","title":"A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants","status":"COMPLETED","sponsor":"Allergan","startDate":"2019-10-11","conditions":"Hypothyroidism, Thyroid Disease, Euthyroid","enrollment":284},{"nctId":"NCT06408909","phase":"NA","title":"Pharmacist Role in Thyroid Disorders","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2022-03-15","conditions":"Hypothyroidism, Hyperthyroidism, Thyroid Diseases","enrollment":44},{"nctId":"NCT00648557","phase":"PHASE1","title":"Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2003-01","conditions":"Healthy","enrollment":32},{"nctId":"NCT00648700","phase":"PHASE1","title":"Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-08","conditions":"Healthy","enrollment":32},{"nctId":"NCT00648882","phase":"PHASE1","title":"Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2007-03","conditions":"Healthy","enrollment":33},{"nctId":"NCT00647855","phase":"PHASE1","title":"Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2003-05","conditions":"Healthy","enrollment":30},{"nctId":"NCT06353555","phase":"NA","title":"Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-10-11","conditions":"Intracerebral Hemorrhage, Low T3 Syndrome, Neurocritical Care","enrollment":100},{"nctId":"NCT02320669","phase":"PHASE3","title":"Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Seattle Children's Hospital","startDate":"2014-11","conditions":"Congenital Heart Defects","enrollment":220},{"nctId":"NCT06346236","phase":"","title":"Neurodevelopmental Impact of Treatment in Hypothyroxinaemia of Prematurity.","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2020-03-01","conditions":"Transient Hypothyroxinemia of Prematurity","enrollment":373},{"nctId":"NCT06151548","phase":"PHASE4","title":"Effect of Krill Oil Supplementation on Red Blood Cell Physiology Against Changes in Markers of Iron Metabolism.","status":"UNKNOWN","sponsor":"Poznan University of Physical Education","startDate":"2024-03-23","conditions":"Red Blood Cell Disorder, Oxidative Stress, Iron Metabolism Disorders","enrollment":30},{"nctId":"NCT06271434","phase":"NA","title":"Effects of Krill Oil on Intestinal Integrity Markers in Elite Rowers.","status":"UNKNOWN","sponsor":"Poznan University of Physical Education","startDate":"2024-03-23","conditions":"Endothelial Dysfunction","enrollment":30},{"nctId":"NCT05080491","phase":"NA","title":"Thyroid Profile in Attention Deficit With Hyperactivity Disorder (ADHD)","status":"UNKNOWN","sponsor":"Fondation Lenval","startDate":"2023-11-21","conditions":"Attention Deficit With Hyperactivity Disorder","enrollment":400},{"nctId":"NCT02725879","phase":"","title":"FGF-21 Levels and RMR in Children and Adolescents With Hashimoto's Thyroiditis (THYROMETABOL)","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2015-10","conditions":"Hashimoto Disease","enrollment":90},{"nctId":"NCT05733078","phase":"PHASE2","title":"Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism","status":"UNKNOWN","sponsor":"Dr Adnan Agha","startDate":"2023-11-01","conditions":"Hypothyroidism, Primary Hypothyroidism, Vitamin C Deficiency","enrollment":40},{"nctId":"NCT04415658","phase":"PHASE3","title":"Intravenous Thyroxine for Heart-Eligible Organ Donors","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-12-01","conditions":"Brain Death, Heart Failure","enrollment":838},{"nctId":"NCT05461820","phase":"PHASE4","title":"Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2018-05-01","conditions":"Graves Disease, Relapse, Treatment","enrollment":240},{"nctId":"NCT05316922","phase":"PHASE3","title":"TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients","status":"RECRUITING","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","startDate":"2021-12-13","conditions":"Hypothyroidism; Irradiation","enrollment":68},{"nctId":"NCT06135948","phase":"PHASE4","title":"Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism","status":"COMPLETED","sponsor":"Emirates Health Services (EHS)","startDate":"2022-03-15","conditions":"L-thyroxine","enrollment":103},{"nctId":"NCT04288115","phase":"PHASE4","title":"Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2021-03-24","conditions":"Subclinical Hypothyroidism","enrollment":52},{"nctId":"NCT05182931","phase":"PHASE2","title":"A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)","status":"UNKNOWN","sponsor":"Olivia Newton-John Cancer Research Institute","startDate":"2022-07-14","conditions":"Thyroid Cancer","enrollment":80},{"nctId":"NCT04964284","phase":"PHASE3","title":"Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer","status":"UNKNOWN","sponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","startDate":"2021-10-06","conditions":"Differentiated Thyroid Cancer","enrollment":328},{"nctId":"NCT06087068","phase":"PHASE2","title":"Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2022-08-01","conditions":"Thyroid Cancer, Surgery, Recurrence","enrollment":140},{"nctId":"NCT05551455","phase":"NA","title":"Endocrinological and Physiological Responses to Short-term Reduced Carbohydrate Availability in Males","status":"COMPLETED","sponsor":"Liverpool John Moores University","startDate":"2022-05-04","conditions":"Energy Supply; Deficiency, Carbohydrate Availability","enrollment":8},{"nctId":"NCT06033456","phase":"NA","title":"Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome","status":"UNKNOWN","sponsor":"National Cancer Institute, Egypt","startDate":"2023-10-07","conditions":"Stellate Ganglion, Radiofrequency Ablation, Complex Regional Pain Syndromes","enrollment":150},{"nctId":"NCT05270798","phase":"PHASE2","title":"Thyroid Hormone Supplementation in Patients With Septic Shock","status":"COMPLETED","sponsor":"Cantonal Hospital Zenica","startDate":"2022-05-01","conditions":"Euthyroid Sick Syndromes, Septic Shock","enrollment":108},{"nctId":"NCT06036576","phase":"PHASE3","title":"Thyroxine Therapy for Recurrent Pregnancy Loss in Hypothyroid Women","status":"COMPLETED","sponsor":"Al-Kindy College of Medicine","startDate":"2022-03-01","conditions":"Recurrent Early Pregnancy Loss, Thyroid Diseases","enrollment":77},{"nctId":"NCT04747275","phase":"PHASE4","title":"Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients","status":"TERMINATED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2021-01-18","conditions":"Hypothyroidism, Trisomy 21","enrollment":6}],"_emaApprovals":[],"_faersSignals":[{"count":1122,"reaction":"FATIGUE"},{"count":863,"reaction":"DIARRHOEA"},{"count":856,"reaction":"NAUSEA"},{"count":603,"reaction":"DRUG INEFFECTIVE"},{"count":602,"reaction":"DEATH"},{"count":572,"reaction":"DYSPNOEA"},{"count":561,"reaction":"HEADACHE"},{"count":551,"reaction":"PAIN"},{"count":535,"reaction":"DIZZINESS"},{"count":499,"reaction":"FALL"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL2103741"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":88,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"levothyroxin","genericName":"levothyroxin","companyName":"Ain Shams University","companyId":"ain-shams-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:23:59.388800+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}